EKM Scientific Advisory Board Members

 

Thomas D.Y. Chung, Ph.D. -
President, Scientific Consultants

 

Thomas is the Chair of the Scientific Advisory Board.  Chung, who focuses on the knowledge management and electronic laboratory notebook areas, is also an independent consultant and specializes in assisting fast growth life sciences companies and major pharmaceutical companies in strategies for the development, implementation and integration of novel technologies in the drug discovery area, and in making critical assessments as to whether these technologies are likely to be successfully commercialized and demonstrate the required return-on-investment. He has experience in a broad range of life sciences specialties including the pharmaceutical, biotechnology and medical device areas. Chung brings more than 18 years of experience as a scientist and R&D executive with four major pharmaceutical companies – including DuPont Pharmaceutical Co. and Bristol-Myers Squibb – and a successful venture-backed life sciences company. At DuPont, he built, managed and strategically positioned a world-class lead discovery operation that was responsible for early drug discovery. He had a leadership role in evaluating novel technologies for acquisition by DuPont and in designing and implementing development strategies following their acquisition.

 

Chung has a Bachelor’s of Science degree in chemistry from MIT, and a Ph.D. in bio-inorganic chemistry from the University of California at Berkeley. He has published more than 30 peer-reviewed articles in a diverse group of scientific journals, and holds three patents and seven pending applications for inventions he co-created. 

 

 

Chris Coppin M.D., Ph.D. -

Senior Research Manager,

Medtronic Heart Valves

 

Chris Coppin grew up in Brussels, Belgium.  He received his education in Boston, at MIT and Tufts University, earning degrees in physics, cellular physiology and medicine.  He developed a strong interest in scientific instrumentation and automation while investigating the biophysics of molecular motors at UCSF.  Dr. Coppin then applied his skills in high throughput research automation in the biotech and pharma industries before moving into medical devices.  For the last five years, Dr. Coppin has been leading the research department at Medtronic Heart Valves, comprising scientists and surgeons in laboratories across four continents.  His team is developing cutting edge technologies for tissue engineering and automated device testing.  To contend with the flood of scientific data produced by automated research instruments, Dr. Coppin’s staff relies entirely on Electronic Lab Notebook technology.

 

 

 


Roger Fraumann -

EF Consulting,

President

 

Roger Fraumann is an information technology and business development professional with over 25 years of experience in global business development, strategic marketing and sales. His expertise includes worldwide partner, supplier and sales channel development, contract negotiations and business intelligence. A frequent advisor and speaker, he is often asked to discretely resolve intractable business development challenges.  In 1989, he co-founded EFConsulting (EFC) to provide personalized marketing and business development services for select clients. Roger frequently draws on his extensive experience and contacts across the computer, networking and high technology industries to provide targeted research and initial business overtures. Clients often consult with Roger for highly creative and results-oriented problem solving. His strong inter-personal skills contribute to rapidly building strong alliances and teams.  Roger has held various management positions in organizations and was most recently affiliated with IBM where he lead business development efforts across Asia. Other affiliations include: NCR, BEA Systems, UNIX International, BeXcom and BioQ. He also served in the U.S. Air Force where he held a Top Secret Crypto Clearance.

 


Daniel R. Henderson, Ph.D.

President and Co-Founder,

PaxVax, Inc.

 

 

Daniel has an extensive scientific and medical background, as well as seasoned experience in raising capital in today’s competitive tech market. Henderson, former president and CEO of San Diego-based Arizeke Pharmaceuticals, has helped raise more than $40 million for two life science companies, Calydon, Inc. and Microgenics Corp. He sold Microgenics in 1992 diagnostics giant Boehringer-Mannheim for $60 million. Boehringer-Mannheim is now part of pharmaceutical leader Roche. Henderson – who invented the ARCA family of anti-cancer therapeutics while at Calydon – has been a visiting scholar at Stanford University Medical Center. He holds a Bachelor’s Degree from UC Berkeley and a Ph.D. from the University of New Mexico Medical Center. He was a postdoctoral fellow at Duke University Medical Center.

Jay Kunin, Ph.D. -

 

Jay is a pharmaceutical and medical information technology consultant, and an expert in regulatory compliance of IT systems. Kunin, who began his tech career in software research at Massachusetts General Hospital, has been a consultant to vendors such as Oracle, RelSys, Sun, DEC and IBM, and biomedical and healthcare firms, including Genentech, Amgen, Marion Merrill Dow, and Scripps Clinic. He was director of IT at Scios, Inc. (now part of Johnson & Johnson), and was the founder and president of RxSys International, a public company that made clinical trials systems for Sandoz, among others. Kunin was also a principal of Securities Industry Software Corp, where he served as VP of Technology and, later, VP International, when the company was acired quby CitiCorp. Kunin serves on the academic advisory board for UCSD’s Integrated New Product Development program, and for UCLA Anderson School’s Biotech Executive Program. He’s a Management Fellow at UCSD CONNECT, an advisor to several VC firms, a director or advisor for several startup medical technology companies, and a member of the Board of Directors of the San Diego Tech Coast Angels. Kunin holds a Bachelor’s Degree in physical sciences and a Ph.D. in Computer Science from MIT.

 

 

 

 

Gerry Martin -

Vice President, Corporate Licensing and Technology Alliances,

Retired Abbott Laboratories

 

Gerry, a life sciences consultant, has more than three decades of life sciences and business leadership under his belt. Martin is a member of the founding committee of the Life Sciences Information Technology (LSIT) Global Institute, a San Diego-based nonprofit launched to facilitate collaborations that create open source LSIT architectures that enable Good Informatics Practices and accelerate improvements in global public health. Martin spent 30 years at Abbott Laboratories, where he was Vice President, Corporate Licensing and Technology Alliances. He and his team were responsible for planning and executing multi-divisional business strategies, including in/out licensing and global alliances on a global basis for Abbott's various divisions. Martin began his career at Abbott in 1970 in sales. In 1980, he became director of Abbott’s operations in the Soviet Union, where he was responsible for managing the company's initiatives in opening up that market. Martin continued to move up the management chain, including becoming director of strategic planning and vice president of corporate marketing. Martin, who studied psychology, history and sociology at the University of Connecticut, was a U.S. Army reservist for six years. He is a member of several professional organizations, including the CONNECT Advisory Board and the Licensing Executive Society.

 


Mahesh H. Merchant, Ph.D. -

Indiana University,

Associate Professor of Informatics

Laboratory Informatics Graduate Program

 

Mahesh is an associate professor for Indiana University’s Laboratory Informatics/Health Informatics Graduate Program. Mahesh specializes in scientific data management, bioinformatics, chemical informatics, health informatics and GLP validation of Laboratory Information Management Systems (LIMS).

 

Before heading to Indiana University, Mahesh worked for Pharmacia Corp.’s Bioinformatics/Information Technology group, where he developed databases and new tools for data mining (Pfizer, Inc. has since acquired Pharmacia). Mahesh also integrated LIMS for acquisition, analysis, and archiving of DNA-micro array chips and 3D protein crystal structures. He implemented a system for global pharmaceutical supply that required GLP validation. Mahesh also worked for four years at Physio Control Corporation developing a multi-lead electrocardiograph system for detecting coronary artery disease and ischemia, a condition in which the blood flow inside a coronary artery is restricted by a partial or complete blockage. He and his colleagues developed the system while at the University of Utah. As a former software engineer for Utah-based Evans & Sutherland, he developed a planetarium system and high-end flight simulators. He has installed a computer system to monitor patients in the burn and trauma unit and integrated it with the Hospital Information System. He holds a Master’s Degree in Electrical Engineering from California State University, Long Beach, and a Ph.D. in Medical Biophysics and Computing from the University of Utah.